Biohaven (BHVN) Net Cash Flow (2021 - 2026)

Biohaven (BHVN) has 6 years of Net Cash Flow data on file, last reported at $44.3 million in Q1 2026.

• For the quarter ending Q1 2026, Net Cash Flow rose 35633.87% year-over-year to $44.3 million; the trailing twelve-month figure through Mar 2026 stood at $174.4 million (up 306.8% YoY), and the FY2025 full-year result was $130.2 million, up 187.03% from the prior year.
• Net Cash Flow held at $44.3 million in Q1 2026, from $44.4 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $190.8 million in Q4 2022 to a low of -$154.3 million in Q3 2024.
• A 5-year average of $11.8 million and a median of $14.4 million in 2024 frame the typical range for Net Cash Flow.
• Across the five-year window, Net Cash Flow sank 376.48% in 2023 and surged 35633.87% in 2026, its largest moves.
• Tracing BHVN's Net Cash Flow over 5 years: stood at $190.8 million in 2022, then plunged by 33.72% to $126.4 million in 2023, then slumped by 88.58% to $14.4 million in 2024, then jumped by 207.55% to $44.4 million in 2025, then decreased by 0.19% to $44.3 million in 2026.
• Business Quant data shows BHVN's Net Cash Flow at $44.3 million in Q1 2026, $44.4 million in Q4 2025, and $19.4 million in Q3 2025.